Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2008-7-7
pubmed:abstractText
The apolipoprotein A5 gene (APOA5) is a key player in determining triglyceride concentrations in humans and mice. Since diabetes is often associated with hypertriglyceridemia, this study explores whether APOA5 gene expression is regulated by alteration in glucose homeostasis and the related pathways. d-Glucose activates APOA5 gene expression in a time- and dose-dependent manner in hepatocytes, and the glycolytic pathway involved was determined using d-glucose analogues and metabolites. Together, transient transfections, electrophoretic mobility shift assays and chromatin immunoprecipitation assays show that this regulation occurs at the transcriptional level through an increase of USF1/2 binding to an E-box in the APOA5 promoter. We show that this phenomenon is not due to an increase of mRNA or protein expression levels of USF. Using protein phosphatases 1 and 2A inhibitor, we demonstrate that d-glucose regulates the APOA5 gene via a dephosphorylation mechanism, resulting in an enhanced USF1/2-promoter binding. Last, subsequent suppressions of USF1/2 and phosphatases mRNA through siRNA gene silencing abolished the regulation. We demonstrate that the APOA5 gene is up regulated by d-glucose and USF through phosphatase activation. These findings may provide a new cross-talk between glucose and lipid metabolism.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1089-8638
pubmed:author
pubmed:issnType
Electronic
pubmed:day
25
pubmed:volume
380
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
789-98
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:18572192-Animals, pubmed-meshheading:18572192-Apolipoproteins A, pubmed-meshheading:18572192-Cell Line, pubmed-meshheading:18572192-Cell Line, Tumor, pubmed-meshheading:18572192-Dose-Response Relationship, Drug, pubmed-meshheading:18572192-Enzyme Activation, pubmed-meshheading:18572192-Enzyme Inhibitors, pubmed-meshheading:18572192-Gene Expression Regulation, pubmed-meshheading:18572192-Glucose, pubmed-meshheading:18572192-Glycolysis, pubmed-meshheading:18572192-Hepatocytes, pubmed-meshheading:18572192-Humans, pubmed-meshheading:18572192-Promoter Regions, Genetic, pubmed-meshheading:18572192-Protein Binding, pubmed-meshheading:18572192-Protein Phosphatase 1, pubmed-meshheading:18572192-Protein Phosphatase 2, pubmed-meshheading:18572192-RNA, Messenger, pubmed-meshheading:18572192-Rats, pubmed-meshheading:18572192-Time Factors, pubmed-meshheading:18572192-Transcription, Genetic, pubmed-meshheading:18572192-Upstream Stimulatory Factors
pubmed:year
2008
pubmed:articleTitle
Glucose regulates the expression of the apolipoprotein A5 gene.
pubmed:affiliation
Institut Pasteur de Lille, Département d'Athérosclérose, Lille, France.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't